Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Kwality Pharmaceuticals Ltd.

May 18 BSE 507.10 ( -2.00 -0.39%)

Volume1003

Prev. Close
509.10

Open Price
511.50

Today's Low / High

500.00 511.50

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

248.00 545.00

Kwality Pharmaceuticals Ltd.is not traded in NSE

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	251.03	456.19	262.01	139.30	166.29
Total Operating Revenues	251.03	456.19	262.01	139.30	166.29

Other Income	2.94	3.51	1.59	3.66	0.61
Total Revenue	253.97	459.70	263.60	142.96	166.90

EXPENSES
Cost Of Materials Consumed	113.22	199.31	165.28	91.92	114.06
Purchase Of Stock-In Trade	0.04	3.80	0.22	0.67	0.13
Changes In Inventories Of FG,WIP And Stock-In Trade	-3.20	-2.51	0.09	-5.51	5.25
Employee Benefit Expenses	29.96	20.15	15.90	11.93	8.56
Finance Costs	6.02	2.92	2.67	2.50	2.28
Depreciation And Amortisation Expenses	14.96	10.69	6.49	4.43	3.12
Other Expenses	50.86	63.77	51.67	26.10	22.58
Total Expenses	211.87	298.13	242.33	132.04	155.99

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	42.10	161.57	21.27	10.92	10.91

Exceptional Items	-16.53	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	25.57	161.57	21.27	10.92	10.91

Tax Expenses-Continued Operations
Current Tax	6.48	41.00	5.80	3.00	3.30
Deferred Tax	0.14	0.27	0.16	-0.32	-0.09
Tax For Earlier Years	-0.33	0.35	0.42	0.03	0.14
Total Tax Expenses	6.29	41.63	6.38	2.71	3.35
Profit/Loss After Tax And Before ExtraOrdinary Items	19.28	119.94	14.89	8.21	7.56

Profit/Loss From Continuing Operations	19.28	119.94	14.89	8.21	7.56

Profit/Loss For The Period	19.28	119.94	14.89	8.21	7.56

Minority Interest	0.09	0.05	0.26	0.11	0.00
Consolidated Profit/Loss After MI And Associates	19.37	119.99	15.15	8.32	7.55

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	18.16	115.64	14.60	8.02	7.28
Diluted EPS (Rs.)	18.16	115.64	14.60	8.02	7.28

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	251.03
Total Operating Revenues	251.03
Other Income	2.94
Total Revenue	253.97
EXPENSES
Cost Of Materials Consumed	113.22
Purchase Of Stock-In Trade	0.04
Changes In Inventories Of FG,WIP And Stock-In Trade	-3.20
Employee Benefit Expenses	29.96
Finance Costs	6.02
Depreciation And Amortisation Expenses	14.96
Other Expenses	50.86
Total Expenses	211.87
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	42.10
Exceptional Items	-16.53
Profit/Loss Before Tax	25.57
Tax Expenses-Continued Operations
Current Tax	6.48
Deferred Tax	0.14
Tax For Earlier Years	-0.33
Total Tax Expenses	6.29
Profit/Loss After Tax And Before ExtraOrdinary Items	19.28
Profit/Loss From Continuing Operations	19.28
Profit/Loss For The Period	19.28
Minority Interest	0.09
Consolidated Profit/Loss After MI And Associates	19.37
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	18.16
Diluted EPS (Rs.)	18.16